Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics

Joshua B. Simpson,Morgan E. Walker,Joshua J. Sekela,Samantha M. Ivey,Parth B. Jariwala,Cameron M. Storch,Mark E. Kowalewski,Amanda L. Graboski,Adam D. Lietzan,William G. Walton,Kacey A. Davis,Erica W. Cloer,Valentina Borlandelli,Yun-Chung Hsiao,Lee R. Roberts,David H. Perlman,Xue Liang,Hermen S. Overkleeft,Aadra P. Bhatt,Kun Lu,Matthew R. Redinbo
DOI: https://doi.org/10.1016/j.chom.2024.04.018
IF: 31.316
2024-06-12
Cell Host & Microbe
Abstract:Disruptions in neurotransmitter and hormone levels are connected to diseases ranging from cancer to anxiety. Using multi-omic, in vitro, and in vivo approaches, Simpson et al. identify specific gut microbial β-glucuronidases that influence endobiotic homeostasis and are inhibited by diverse FDA-approved drugs.
microbiology,virology,parasitology
What problem does this paper attempt to address?